Drug intelligence / Profile preview

Kujin Tablet

Development stage: Unknown
Lead developer: Shanghai Pharmaceuticals Group Qingdao Growful Pharmaceutical
Administration: Oral

Overview

Kujin Tablet (苦金片) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanghai Pharmaceuticals Group Qingdao Growful Pharmaceutical. It is formulated to clear heat, detoxify the body, resolve phlegm, and relieve cough. The product is primarily indicated for the treatment of chronic bronchitis and respiratory symptoms associated with lung-heat patterns in TCM theory. As a multi-ingredient botanical formulation, it typically contains extracts from various medicinal herbs, including Sophora flavescens and Lonicera japonica, which are known for their anti-inflammatory and antitussive properties. In China, it is marketed as an over-the-counter (OTC) pharmaceutical product.

Brand names: Kujin Tablet苦金片
Other names: Kujin Pian

Beyond the preview

Go deeper on Kujin Tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kujin Tablet.

Explore the full profile